Molecular Biology Enzymes, Kits, and Reagents Market to record USD 13.09 Bn growth | 39% of growth to originate from North America | Technavio
Molecular Biology Enzymes, Kits, and Reagents Market to record USD 13.09 Bn growth
Jan 26, 2022 by PR Newswire
- The presence of a large number of players and increasing investments in the field of biotechnology are driving the growth of the molecular biology enzymes, kits, and reagents market in North America.
- The US is the key market for molecular biology enzymes, kits, and reagents in North America.
- The molecular biology enzymes, kits, and reagents market is fragmented due to the presence of a large number of players.
- To know about a few other market drivers, trends, and challenges, Download our free sample report Related Reports: Affinity Chromatography Reagents Market by End-user and Geography - Forecast and Analysis 2021-2025 Cell Culture Media and Reagents Market by End-user and Geography - Forecast and Analysis 2021-2025 Molecular Biology Enzymes, Kits, And Reagents Market Scope Report Coverage Details Page number 120 Base year 2020 Forecast period 2021-2025 Growth momentum & CAGR Accelerate at a CAGR of 14.61% Market growth 2021-2025 USD 13.09 billion Market structure Fragmented YoY growth (%) 14.30 Regional analysis North America, Europe, Asia, and ROW Performing market contribution North America at 39% Key consumer countries US, Germany, UK, China, and Japan Competitive landscape Leading companies, competitive strategies, consumer engagement scope Companies profiled Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Rockland Immunochemicals Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc. Market Dynamics Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to email@example.com. © 2021 Kwhen Inc.
Was this content valuable for you?